Cargando…

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

Early diagnosis and treatment of multiple sclerosis (MS) in the initial stages of the disease can significantly retard its progression. The aim of the present study was to identify changes in the cerebrospinal fluid proteome in patients with relapsing-remitting MS and clinically isolated MS syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales:	PAVELEK, ZBYŠEK, VYŠATA, OLDŘICH, TAMBOR, VOJTĚCH, PIMKOVÁ, KRISTÝNA, VU, DAI LONG, KUČA, KAMIL, ŠŤOURAČ, PAVEL, VALIŠ, MARTIN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906564/ https://www.ncbi.nlm.nih.gov/pubmed/27347402 http://dx.doi.org/10.3892/br.2016.668

Ejemplares similares

The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
por: Valis, Martin, et al.
Publicado: (2019)

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis
por: Vališ, Martin, et al.
Publicado: (2023)

Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase
por: Pavelek, Zbyšek, et al.
Publicado: (2020)

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
por: Vališ, Martin, et al.
Publicado: (2022)

Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor
por: Pavelek, Zbysek, et al.
Publicado: (2023)

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy
por: Valis, Martin, et al.
Publicado: (2016)

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
por: Stoop, Marcel P., et al.
Publicado: (2010)

CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate
por: Vališ, Martin, et al.
Publicado: (2019)

Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis
por: Liu, Haijie, et al.
Publicado: (2022)

Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis
por: Peterka, Marek, et al.
Publicado: (2023)

The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine
por: Pavelek, Zbyšek, et al.
Publicado: (2020)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust, Jiří, et al.
Publicado: (2015)

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
por: Herman, Stephanie, et al.
Publicado: (2019)

INTENSIVE CIRCUIT CLASS THERAPY IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
por: KOCICA, Jan, et al.
Publicado: (2022)

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
por: Vališ, Martin, et al.
Publicado: (2020)

In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from Variola virus
por: Garcia, Danielle R., et al.
Publicado: (2021)

Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
por: Matsushita, Takuya, et al.
Publicado: (2013)

Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study
por: Fang, Xingwei, et al.
Publicado: (2023)

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
por: Masopust, Jiří, et al.
Publicado: (2018)

Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
por: Cocuzza, Clementina E., et al.
Publicado: (2014)

Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis
por: Murgia, Federica, et al.
Publicado: (2020)

Quantification of cellular protein and redox imbalance using SILAC-iodoTMT methodology
por: Vajrychova, Marie, et al.
Publicado: (2019)

Correction: Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
Publicado: (2014)

Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis
por: Yonar, Dilek, et al.
Publicado: (2018)

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial
por: Musil, Frantisek, et al.
Publicado: (2018)

Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
por: Pavelek, Zbyšek, et al.
Publicado: (2021)

Comprehensive proteomic investigation of infectious and inflammatory changes in late preterm prelabour rupture of membranes
por: Vajrychová, Marie, et al.
Publicado: (2020)

Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid
por: Geraci, Fabiana, et al.
Publicado: (2018)

Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis
por: Veroni, Caterina, et al.
Publicado: (2015)

MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study
por: Zanghì, Aurora, et al.
Publicado: (2023)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

Microsoft Kinect Visual and Depth Sensors for Breathing and Heart Rate Analysis
por: Procházka, Aleš, et al.
Publicado: (2016)

Trends in the treatment of risk factors for stroke in a Czech stroke unit
por: Simunek, Libor, et al.
Publicado: (2015)

Novelty detection-based approach for Alzheimer’s disease and mild cognitive impairment diagnosis from EEG
por: Cejnek, Matous, et al.
Publicado: (2021)

Simple capacitor-switch model of excitatory and inhibitory neuron with all parts biologically explained allows input fire pattern dependent chaotic oscillations
por: Cejnar, Pavel, et al.
Publicado: (2020)

A Patient With Encephalomyeloradiculoneuropathy Exhibiting a Relapsing–Remitting Clinical Course: Correlation of Serum and Cerebrospinal Fluid Anti-Neutral Glycosphingolipids Antibodies With Clinical Relapse
por: Nanaura, Hitoki, et al.
Publicado: (2018)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis
por: Liu, Shilian, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_114f113ga0hmgd3gv1suq83tbp